Sandoz Inc. has recalled 45,036 cartons of Enoxaparin Sodium Injection, USP (40 mg/0.4 mL), a medication used to prevent blood clots. The product was exposed to improper temperatures during shipping (temperature excursion), which could affect its quality. This recall affects single-dose syringes with an automatic safety device distributed nationwide to hospitals and pharmacies. No injuries or incidents have been reported to date.
Exposure to temperatures outside of the approved storage range can cause the medication to lose its effectiveness or degrade. If the medication is less effective, patients may not receive the intended protection against dangerous blood clots.
You have 2 options:
Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. for Sandoz Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.